Videx Ec 250mg & 400mg Capsule
PDF Leaflet Revision Date: 06 March 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Palliative treatment of adults with advanced HIV infection.
Dosage (summary)
400 mg once daily for u2265 60 kg; 250 mg once daily for < 60 kg.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Not established as safe in pregnancy; avoid breastfeeding.
Key Drug Interactions
- Allopurinol
- Tenofovir disoproxil fumarate
- Ribavirin
Contraindications
- Hypersensitivity to didanosine
- Severe hepatic impairment
Common side effects
- Pancreatitis
- Peripheral neuropathy
- Diarrhoea
- Nausea
- Fatigue
Counselling Points
- Take on an empty stomach
- Monitor for pancreatitis symptoms
- Avoid alcohol
Serious warnings
- Pancreatitis risk
- Lactic acidosis
- Hepatic failure
- Non-cirrhotic portal hypertension
Important Disclaimer
The Videx Ec 250mg & 400mg Capsule professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
